» Articles » PMID: 19950987

Identification of Cell-active Lysine Specific Demethylase 1-selective Inhibitors

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2009 Dec 3
PMID 19950987
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Lysine specific demethylase 1 (LSD1) plays a key role in the regulation of gene expression by removing the methyl groups from methylated Lys4 of histone H3 (H3K4). Here we report the identification of the first small-molecule LSD1-selective inhibitors. These inhibitors show in vivo H3K4-methylating activity and antiproliferative activity and should be useful as lead structures for anticancer drugs and as tools for studying the biological roles of LSD1.

Citing Articles

Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.

Sprussel A, Suzuki T, Miyata N, Astrahantseff K, Szymansky A, Toedling J J Clin Med. 2024; 13(20).

PMID: 39458030 PMC: 11508765. DOI: 10.3390/jcm13206081.


Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum.

Reyser T, Paloque L, Augereau J, Di Stefano L, Benoit-Vical F Malar J. 2024; 23(1):44.

PMID: 38347549 PMC: 10863139. DOI: 10.1186/s12936-024-04855-9.


Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.

Mao F, Shi Y Adv Exp Med Biol. 2023; 1433:15-49.

PMID: 37751134 DOI: 10.1007/978-3-031-38176-8_2.


Chemical modulation of lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes.

Padalino G, Celatka C, Rienhoff Jr H, Kalin J, Cole P, Lassalle D Wellcome Open Res. 2023; 8:146.

PMID: 37520936 PMC: 10375057. DOI: 10.12688/wellcomeopenres.18826.1.


LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials.

Noce B, Di Bello E, Fioravanti R, Mai A Front Pharmacol. 2023; 14:1120911.

PMID: 36817147 PMC: 9932783. DOI: 10.3389/fphar.2023.1120911.